Clinical Trial Update: A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating HSK21542 for postoperative pain completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Analgesia

Drugs mentioned

• HSK21542

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Postoperative Analgesia | Phase 3 | Status: COMPLETED